LMNA and cardiomyopathy: Lmna H222P/H222P embryonic hearts showed noncompaction, dilatation, and decreased heart function already at E13.5[75], while Lmna+/− and Lmna−/− embryonic hearts showed noncompaction cardiomyopathy with no decrease in ejection fraction [63].